CONTINUING MEDICAL EDUCATION (CME) CREDIT
Learner Notification
International Society of Glomerular Disease
2025 International Podocyte Conference
June 11 - 13, 2025 Hamburg, Germany
Acknowledgement of Financial Commercial Support
Sanofi
PPD
Travere
Vera Therapeutics
NIPOKA
Regeneron
CSL Vifor
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion.Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/ certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society of Glomerular Disease. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
Physicians
Amedco LLC designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
International CME Accreditation
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. ACCME / AMA PRA Category 1 CreditsTM carry reciprocity with EACCME member countries and most international licensing bodies for physicians, with some exceptions. Physicians should check with their country/board for eligibility.
The UEMS-EACCME and the AMA has a signed agreement of mutual recognition of CME credits between Europe and USA for live and e-learning activities. A list of active collaborations can be found here:
European Collaborations: https://eaccme.uems.eu/collaborations-european
All Others: https://eaccme.uems.eu/international-collaborations
The EACCME® has signed agreements with the following countries: Austria, Armenia, Belgium, Bulgaria, Canada, Croatia, Cyprus, Finland, Georgia, Greece, Hungary, Ireland, Latin America (See below), Lombardia, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Tunisia, Turkey, United Kingdom, United States CONFEMEL (Confederación médica latinoiberoamericana y del caribe) is the organization that represents and is made up of all the titular medical institutions with national representation, the founding institutions and the adherents of the countries of Latin America and the Caribbean. The countries of Latin America and the Caribbean within the scope of the agreement between UEMS-EACCME® , CONFEMEL and CGCOM-SEAFORMEC will be divided by regions for the operation of CONFEMEL, being the same: Andean Region: Bolivia, Colombia, Ecuador, Peru and Venezuela; Central American and Caribbean Region: Costa Rica, Guatemala, Haiti, Honduras, El Salvador, Mexico, Dominican Republic, Nicaragua, Panama and Puerto Rico, among others; South Region: Argentina, Brazil, Chile, Paraguay and Uruguay. The EACCME® shall grant ECMEC® credits to National events taking place in Latin America and organised by Latin American providers part of or belonging to CONFEMEL. The applications related to National events shall be submitted through the SEAFORMEC/SMPAC platform for accreditation according to the agreement entered into between UEMS-EACCME® and CGCOM.
Objectives
After Attending This Program You Should Be Able To
1. Identify recent discoveries in basic, translational, and clinical research in glomerular biology and glomerular diseases;2. Identify new research questions based on current scientific and clinical advances in disciplines related to glomerular biology and glomerular diseases
3. Translate recent advances in the aforementioned areas into new standards and approaches to clinical care of patients with glomerular diseases and related disorders.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
| Name | Commercial Interest:Relationship |
| Jonathan Barratt | Novartis, Travere, Vera, Otsuka, Alexion, AstraZeneca, Calliditas, Vertex, Biogen, Takeda:Consultant Alnylam, Argenx, Astellas, BioCryst, Calliditas, Chinook, Dimerix, Galapagos, Novartis, Omeros, Travere Therapeutics, Vera Therapeutics, Visterra:Consultant Argenx, Calliditas, Chinook, Galapagos, GlaxoSmithKline, Novartis, Omeros, Travere Therapeutics, Visterra:Research Grant Overall Principal Investigator |
| Thomas Benzing | NA |
| Andreas Beyer | NA |
| Fabian Braun | Amicus Therapeutics, Takeda Pharmaceuticals:Consultant Amicus Therapeutics, Chiesi:Research Grant Site Principal Investigator Takeda Pharmaceuticals Amicus Therapeutics Sanofi-Genzyme, Chiesi:Scientific/Medical Advisory Board Member |
| Paul Brinkkötter | CSL Vifor, Sanofi, AstraZeneca, Boehringer Ingelheim, Novartis, Roche, Takeda:Scientific/Medical Advisory Board Member |
| Silke Brix | CSL Vifor:Scientific/Medical Advisory Board Member CSL Vifor:Speakers Bureau |
| Chee Kay Cheung | Travere Therapeutics:Research Grant Overall Principal Investigator Alexion, Boehringer Ingelheim, Calliditas, CSL Vifor, George Clinical, Novartis, Otsuka Pharmaceutical, Roche, Travere Therapeutics, Stada, Vera Therapeutics, Vertex:Consultant |
| Rebecca Cook | NA |
| Laurel Damashek | NA |
| Bernhard Dumoulin | NA |
| Nicole Endlich | NA |
| Lioba Ester | NA |
| Alessia Fornoni | Zyversa Therapeutics, Renal3River:Patent Holder Vera Therapeutics, Bayer, Astra Zeneca, Novartis, Dimerix, Fortress Biotech:Consultant UpToDate, Pano Therapeutics:Private Stock Shareholder Novartis:Owner |
| Brian Kennedy | NA |
| Krzysztof Kiryluk | NA |
| Sybille Köhler | NA |
| Anna Köttgen | NA |
| Rafael Kramann | Bayer:Consultant |
| Matthias Kretzler | Boehringer-Ingelheim, Certa, Travere, Maze therapeutics, Roche, Astra-Zeneca, Novo Nordisk, Moderna, Chinook, Angion Pharmaceuticals, RenalytixAI, Eli Lilly, Gilead, Regeneron, Janssen, Vera Therapeut:Research Grant Overall Principal Investigator |
| Rachel Lennon | Calliditas, Visterra, Purespring:Consultant Alport UK, Alport syndrome Foundation:Scientific/Medical Advisory Board Member FourPoints Innovation, NovoNordisk:Research Grant Overall Principal Investigator |
| Christoph Licht | NA |
| Liz Lightstone | Alexion, Astra Zeneca, Boehringer, GSK, Novartis, Roche:Scientific/Medical Advisory Board Member Argenx, Kezar:Consultant Carna Health:Private Stock Shareholder GSK, Otsuka, Pfizer, Roche:Speakers Bureau Nkarta, Novartis:Other |
| Laura Mariani | Novartis, Dimerix, Vera, Travere Therapeutics, Boehringer-Ingelheim:Scientific/Medical Advisory Board Member Takeda , Calliditas Therapeutics, Reliant Glycosciences, Hi Bio:Research Grant Overall Principal Investigator Otsuka:Other |
| Catherine Meyer-Schwesinger | NA |
| Jeffrey Miner | Sintra Therapeutics:Private Stock Shareholder Visterra, SonoThera, Travere, Alcimed, Eloxx:Consultant Keros:Research Grant Overall Principal Investigator |
| Angel Morales | NA |
| Carla Nester | Novartis, Apellis, Biocryst, Retrophin:Research Grant Site Principal Investigator Novartis, Apellis, Biocryst, AstraZenaca:Consultant Vertex:Scientific/Medical Advisory Board Member |
| Glory Onwuka | NA |
| Ulf Panzer | NA |
| Markus Rinschen | Novo Nordisk A/S:Research Grant Overall Principal Investigator |
| Paola Romagnani | NA |
| Boehringer, Regeneron, Calico, Genentech, AZ, ONO:Research Grant Site Principal Investigator |
|
| Mariya Sweetwyne | NA |
| Sydney Tang | Boehringer Ingelheim, Novartis, Travere:Scientific/Medical Advisory Board Member |
| Josh Tarnoff | Creegh Pharmaceuticals:Corporate Board Member |
| Pierre-Louis Tharaux | Vifor CSL:Scientific/Medical Advisory Board Member |
| Nicola Tomas | Merida Bioscience:Consultant AstraZeneca, CSL Vifor:Speakers Bureau |
| Marina Vivarelli | Novartis, Alexion:Scientific/Medical Advisory Board Member SOBI, Santhera, PureSpring, Apellis, Roche:Consultant Roche, SOBI, NOvartis, Glaxo, Alexion, Vifor, Travere, WebMD:Speakers Bureau Bayer, Chinook, Roche, Apellis, Novartis, Alexion, Travere: Local PI for clinical trial:Other |
| Shikha Wadhwani | Boehringer Ingelheim, Calliditas, Novartis, Otsuka, Travere, Vera :Scientific/Medical Advisory Board Member Calliditas, Kezar, Travere, Vera:Research Grant Site Principal Investigator |
| Astrid Weins | Euroimmun:Patent Holder Vera Therapeutics:Scientific/Medical Advisory Board Member Sysmex:Other Brigham and Women's Hospital:Employee |
| André Weinstock | NA |
| Hong Zhang | Novartis, Calliditas, Otsuka, Roche, Vertex/ Alpine, Vera, Biogen:Consultant |
| Laurel Damashek | NA |
| Ava Krmpotich | NA |